Director dealings: Oxford Biomedica chair ups stake.
The largest market purchase of shares in London on Thursday came from Oxford Biomedica's chair Roch Doliveux. who upped his stake in the cell and gene therapy company after a sharp drop in the stock over the year to date.
Oxford Biomedica
24 September 2026 17:41:54
Source: Sharecast
Doliveux, has been at the helm of the board since 2020, bought 20,250 shares at a price of 505p each, spending a total of £102,262.50.
OXB's share price closed Wednesday's session at 481p, having lost over a quarter of its value since the start of 2026.
After the latest purchase, Oxford Biomedica said Doliveux owns 459,055 shares, equivalent to 0.379% of the company’s issued share capital.
Halifax is not responsible for the content and accuracy of the Markets News articles. We may not share the views of the author. Understand the risks, please remember the value of your investment can go down as well as up and you may not get back the full amount you invest. We don't provide advice so if you are in any doubt about buying and selling shares or making your own investment decisions we recommend you seek advice from a suitably qualified Financial Advisor. Past performance is not a guide to future performance.